SELLAS Life Sciences Group, Inc.
SLS • NASDAQ
SELLAS Life Sciences Group, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Angelos Stergiou, with a market cap of $783.9M.
CEOAngelos Stergiou
Next Earnings
Upcoming earnings announcement for SELLAS Life Sciences Group, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.06
Earnings History
Past 11 earnings reports for SELLAS Life Sciences Group, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.05Est: -$0.06 | +16.7% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.06Est: -$0.08 | +25.0% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.07Est: -$0.08 | +12.5% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.07Est: -$0.11 | +36.4% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.08Est: -$0.11 | +27.3% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.10Est: -$0.13 | +23.1% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.13Est: -$0.17 | +23.5% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.21Est: -$0.16 | -31.2% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.25Est: -$0.21 | -19.0% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.33 | — | -Est: $8.7M | -100.0% | — |
| Aug 10, 2023 | Q2 2023 | -$0.31Est: -$0.35 | +11.4% | -Est: $3.3M | -100.0% | 10-Q |